ORMP

#3814
Oramed Pharmaceuticals Inc.
3.80 USD
+0.26%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
3.80
3.80
年范围
1.98
3.80
日变化
+0.26%
每月变动
+11.44%
6个月变化
+61.70%
年变化
+71.95%
前一天收盘价
3.79
开盘价
3.80
买价
卖价
最低价
3.80
High
3.80
交易量
9
展开完整图表

Financials

概览 声明 统计 股息
每季度 年度
  • Market Capitalization 153.7 M
  • Employee 13
  • Founded 2006
  • CEO Nadav Kidron
  • Website www.oramed.com
  • Headquarter Delaware, United States
  • FIGI BBG000LRYR36
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
1.9
市销率
60.45
每股股息
0.25
股息收益率 %
8.77

Oramed Pharmaceuticals Inc

Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.

新闻